BioSpace News Archive

BioMidwest

Study: Preclinical Mouse Model Shows Cognitive Improvement in Down Syndrome

Partner Therapeutics, based in Lexington, Mass., has teamed up with the University of Colorado to study mouse models of Down syndrome and compounds that might improve memory with age.

March 30, 2022
·
3 min read
·
Mark Terry
Drug Development

Oscars Slap Shines New Spotlight on Alopecia Areata

Despite being represented in clinical research, no solutions have been found to circumvent the effects of Alopecia areata. However, there may be hope.

March 30, 2022
·
2 min read
·
Jazmine Colatriano M.S.
Drug Development

Biogen Submits Final Plan for Confirmatory Aduhelm Trial

Biogen will await word after submitting the final study protocol for its confirmatory Phase IV ENVISION trial of Aduhelm to the U.S. Food and Drug Administration (FDA).

March 30, 2022
·
2 min read
·
Vanessa Doctor, MS
Business

Merck’s Acceleron Integration To Take Out 143 Jobs in Cambridge, MA

Merck announced that it will be laying off 143 people from the Cambridge, Massachusetts-based Acceleron.

March 30, 2022
·
3 min read
·
Mark Terry
Drug Development

Amylyx ALS Candidate Denied in Painfully Close AdCom Vote (Updated)

In a meeting of the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee, six members voted not to approve the NDA for Amylyx’s ALS candidate, AMX0035, while four voted in favor.

March 30, 2022
·
4 min read
·
Heather McKenzie
FDA

Honing in On Neurometabolic Diseases, Orchard Slashes 30% of Workforce

Orchard Therapeutics announced today that it intends to focus its hematopoietic stem cell (HSC) gene therapy platform exclusively on severe neurometabolic diseases and early research programs.

March 30, 2022
·
2 min read
·
Hayley Shasteen
Drug Development

Safety Concerns Doom Akebia’s Chronic Kidney Disease Drug

The FDA has rejected Cambridge, Mass.-based Akebia Therapeutics’ New D2rug Application (NDA) for vadadustat, a therapeutic for anemia due to chronic kidney disease (CKD).

March 30, 2022
·
2 min read
·
Rosemary Scott
Drug Development

Roche Strikes Out in Difficult-to-Treat Small-Cell Lung Cancer

Interim data from Genentech’s first randomized study on a candidate treatment for extensive-stage small-cell lung cancer failed to meet its co-primary endpoint.

March 30, 2022
·
2 min read
·
Vanessa Doctor, RN
Eye Allergy Therapeutics Market Projection and Upcoming Trends 2022 | Global Industry Survey

By acting on the H1 receptors, which produce antibodies from the mast cell, traditional eye allergy therapies assist to reduce the symptoms and signs of ocular allergies.

March 30, 2022
·
7 min read
Blood Warmer Devices/Sample Warmer Market Development and Emerging Trends Analysis - Technological Advancement in the Healthcare Industry

The global market for blood warmer devices/sample warmers has witness steady expansion in the recent years and continues to expand at a promising pace.

March 30, 2022
·
6 min read